Showing results (1771-1780 of 1,881) with videos related to

Sort By:
Pageof 189
Cardiovascular Diabetology|February 25, 2022
MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetesShawn Veitch, Makon-Sébastien Njock, Mark Chandy, et al.
The New England Journal of Medicine|April 17, 2018
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung CancerLeena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, et al.
Emerging Infectious Diseases|October 22, 2020
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020Paul K S Chan, Grace Lui, Asmaa Hachim, et al.
Cell Death & Disease|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcomeRobert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
BMC Nephrology|September 14, 2018
A large, international study on post-transplant glomerular diseases: the TANGO projectAudrey Uffing, Maria José Pérez-Sáez, Gaetano La Manna, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patientsLisa A Ridnour, Robert Y S Cheng, William F Heinz, et al.
The Spine Journal : Official Journal of the North American Spine Society|February 2, 2025
Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of adults with osteoporotic vertebral compression fracturesCharles H Cho, Steven W Hwang, Daniel J Mazanec, et al.
Frontiers in Immunology|March 23, 2023
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, Carolyn A Cohen, Xiaofeng Mu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH studyF de Marinis, T M Kim, L Bonanno, et al.
Cancer Research Communications|October 2, 2024
Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Y S Cheng, et al.
Pageof 189